1591366604.png)
Research News
Keeping current on all preeclampsia research
This study suggests that women of different BMI classes might have distinct risk profiles for preeclampsia.
Research is being done to make a medicine that can cure preeclampsia a reality. In this article, researchers asked: what are the candidate medicines being studied currently to prevent or treatment preeclampsia?
This is another study on that journey that shows sFlt1 and PlGF are important proteins in pregnant women’s blood that can tell us about preeclampsia risk.
For this study, researchers asked: what are the barriers to eating a heart healthy diet for women with high blood pressure or a hypertensive disorder of pregnancy?
Peter Joseph Pappas preeclampsia research grant recipients' study titles and reports.
Two articles were published this quarter that both provide updated statistics about trends in preeclampsia and hypertensive disorders of pregnancy in the United States.
In this study, HMOX1 gene variants were different depending on ancestry, and these genetic changes could be contributing to the racial disparity in hypertensive disorders of pregnancy.
These results highlight two new biomarkers with a possibility of being able to predict timing of onset and subtypes of preeclampsia well before preeclampsia is diagnosed.
This group of studies supports the role of our gut microbiome on preeclampsia risk. Future studies may explore changing the gut microbiome (for example by antibiotics, probiotics, or prebiotics) to help prevent preeclampsia.
This study suggests that eating ultra-processed foods can increase risk for preeclampsia.
The Preeclampsia Foundation and the Preeclampsia Foundation Canada have announced that John Snelgrove, MD, MSc, and Samantha Wilson, PhD, are their 2022 Vision Grant research award recipients respectively.
Investigators meeting the research funding program’s criteria are invited to submit Letters of Intent for 2022 proposals by August 22, 2022.